Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 96

Related Citations for PubMed (Select 19387109)

1.

Leptin: a novel therapeutic strategy for Alzheimer's disease.

Tezapsidis N, Johnston JM, Smith MA, Ashford JW, Casadesus G, Robakis NK, Wolozin B, Perry G, Zhu X, Greco SJ, Sarkar S.

J Alzheimers Dis. 2009;16(4):731-40. doi: 10.3233/JAD-2009-1021. Review.

2.

Leptin reduces pathology and improves memory in a transgenic mouse model of Alzheimer's disease.

Greco SJ, Bryan KJ, Sarkar S, Zhu X, Smith MA, Ashford JW, Johnston JM, Tezapsidis N, Casadesus G.

J Alzheimers Dis. 2010;19(4):1155-67. doi: 10.3233/JAD-2010-1308.

3.

Leptin regulates tau phosphorylation and amyloid through AMPK in neuronal cells.

Greco SJ, Sarkar S, Johnston JM, Tezapsidis N.

Biochem Biophys Res Commun. 2009 Feb 27;380(1):98-104. doi: 10.1016/j.bbrc.2009.01.041. Epub 2009 Jan 21.

4.

Leptin induces proliferation of neuronal progenitors and neuroprotection in a mouse model of Alzheimer's disease.

Pérez-González R, Antequera D, Vargas T, Spuch C, Bolós M, Carro E.

J Alzheimers Dis. 2011;24 Suppl 2:17-25. doi: 10.3233/JAD-2011-102070.

PMID:
21335656
5.

Leptin boosts cellular metabolism by activating AMPK and the sirtuins to reduce tau phosphorylation and β-amyloid in neurons.

Greco SJ, Hamzelou A, Johnston JM, Smith MA, Ashford JW, Tezapsidis N.

Biochem Biophys Res Commun. 2011 Oct 14;414(1):170-4. doi: 10.1016/j.bbrc.2011.09.050. Epub 2011 Sep 17.

6.

Therapeutic approaches of leptin in Alzheimer's disease.

Carro EM.

Recent Pat CNS Drug Discov. 2009 Nov;4(3):200-8. Review.

PMID:
19891599
7.

Amyloid reduction by amyloid-beta vaccination also reduces mouse tau pathology and protects from neuron loss in two mouse models of Alzheimer's disease.

Wilcock DM, Gharkholonarehe N, Van Nostrand WE, Davis J, Vitek MP, Colton CA.

J Neurosci. 2009 Jun 24;29(25):7957-65. doi: 10.1523/JNEUROSCI.1339-09.2009. Erratum in: J Neurosci. 2010 Jan 20;30(3):1197-8.

8.

Leptin reduces Alzheimer's disease-related tau phosphorylation in neuronal cells.

Greco SJ, Sarkar S, Johnston JM, Zhu X, Su B, Casadesus G, Ashford JW, Smith MA, Tezapsidis N.

Biochem Biophys Res Commun. 2008 Nov 21;376(3):536-41. doi: 10.1016/j.bbrc.2008.09.026. Epub 2008 Sep 16.

9.

Leptin inhibits glycogen synthase kinase-3beta to prevent tau phosphorylation in neuronal cells.

Greco SJ, Sarkar S, Casadesus G, Zhu X, Smith MA, Ashford JW, Johnston JM, Tezapsidis N.

Neurosci Lett. 2009 May 22;455(3):191-4. doi: 10.1016/j.neulet.2009.03.066. Epub 2009 Mar 25.

10.

Alzheimer's disease.

De-Paula VJ, Radanovic M, Diniz BS, Forlenza OV.

Subcell Biochem. 2012;65:329-52. doi: 10.1007/978-94-007-5416-4_14. Review.

PMID:
23225010
11.

Contributions of brain insulin resistance and deficiency in amyloid-related neurodegeneration in Alzheimer's disease.

de la Monte SM.

Drugs. 2012 Jan 1;72(1):49-66. doi: 10.2165/11597760-000000000-00000. Review.

PMID:
22191795
12.

Leptin and ghrelin prevent hippocampal dysfunction induced by Aβ oligomers.

Martins I, Gomes S, Costa RO, Otvos L, Oliveira CR, Resende R, Pereira CM.

Neuroscience. 2013 Jun 25;241:41-51. doi: 10.1016/j.neuroscience.2013.02.062. Epub 2013 Mar 16.

PMID:
23506735
13.

Aberrant phosphorylation in the pathogenesis of Alzheimer's disease.

Chung SH.

BMB Rep. 2009 Aug 31;42(8):467-74. Review.

14.

New age of neuroproteomics in Alzheimer's disease research.

Kovacech B, Zilka N, Novak M.

Cell Mol Neurobiol. 2009 Sep;29(6-7):799-805. doi: 10.1007/s10571-009-9358-6. Epub 2009 Feb 19. Review.

PMID:
19225878
15.

Circulating leptin levels and weight loss in Alzheimer's disease patients.

Power DA, Noel J, Collins R, O'Neill D.

Dement Geriatr Cogn Disord. 2001 Mar-Apr;12(2):167-70.

PMID:
11173891
16.

Membrane lipid modifications and therapeutic effects mediated by hydroxydocosahexaenoic acid on Alzheimer's disease.

Torres M, Price SL, Fiol-Deroque MA, Marcilla-Etxenike A, Ahyayauch H, Barceló-Coblijn G, Terés S, Katsouri L, Ordinas M, López DJ, Ibarguren M, Goñi FM, Busquets X, Vitorica J, Sastre M, Escribá PV.

Biochim Biophys Acta. 2014 Jun;1838(6):1680-92. doi: 10.1016/j.bbamem.2013.12.016. Epub 2013 Dec 27.

PMID:
24374316
17.

Leptin reduces the accumulation of Abeta and phosphorylated tau induced by 27-hydroxycholesterol in rabbit organotypic slices.

Marwarha G, Dasari B, Prasanthi JR, Schommer J, Ghribi O.

J Alzheimers Dis. 2010;19(3):1007-19. doi: 10.3233/JAD-2010-1298.

18.

Alpha1-antichymotrypsin, an inflammatory protein overexpressed in Alzheimer's disease brain, induces tau phosphorylation in neurons.

Padmanabhan J, Levy M, Dickson DW, Potter H.

Brain. 2006 Nov;129(Pt 11):3020-34. Epub 2006 Sep 20.

19.

[Alzheimer's disease: new prospects in therapy and applied experimental models].

Kubis AM, Janusz M.

Postepy Hig Med Dosw (Online). 2008 Aug 5;62:372-92. Review. Polish.

20.

A novel glycogen synthase kinase-3 inhibitor 2-methyl-5-(3-{4-[(S )-methylsulfinyl]phenyl}-1-benzofuran-5-yl)-1,3,4-oxadiazole decreases tau phosphorylation and ameliorates cognitive deficits in a transgenic model of Alzheimer's disease.

Onishi T, Iwashita H, Uno Y, Kunitomo J, Saitoh M, Kimura E, Fujita H, Uchiyama N, Kori M, Takizawa M.

J Neurochem. 2011 Dec;119(6):1330-40. doi: 10.1111/j.1471-4159.2011.07532.x. Epub 2011 Nov 2.

PMID:
21992552
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk